Biomarker pairs for predicting preterm birth
A technology of biomarkers, biological samples, applied in the field of biomarker pairs for predicting preterm birth, can solve problems such as not leading to clinically useful tests
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 2
[0270] Example 2 provides an example of such an analysis.
[0271] In one embodiment, hierarchical clustering is implemented in the derivation of the predictive model, using Pearson correlation as a clustering measure. One approach is to consider the preterm birth data set as a "learning sample" in a "supervised learning" problem. CART is standard in medical applications (Singer, Recursive Partitioning in the Health Sciences, (1999)) and can be modified by: converting any qualitative feature into a quantitative feature; Classification of the level of significance achieved using method evaluation; and suitable application of the lasso method. Indeed, by properly using the Gini classification criterion in regression quality assessment, the prediction problem can be transformed into a regression problem without losing the sight of prediction.
[0272] This method leads to the so-called FlexTree (Huang, Proc.Nat.Acad.Sci.U.S.A 101:10529-10534 (2004)). FlexTree works well when...
Embodiment 1
[0289] Example 1. Establishment of a sample set for the discovery and validation of preterm biomarkers
[0290] Establishment of standard protocols governing the conduct of proteomic evaluation of preterm birth risk (PAPR) clinical studies. Samples were obtained from women at 11 Institutional Review Board (IRB)-approved sites throughout the United States. After providing informed consent, serum and plasma samples were obtained, along with relevant information on patient demographics, past medical and pregnancy history, current pregnancy history, and concurrent drug therapy. After delivery, data are collected on maternal and infant conditions and complications. Serum and plasma samples were processed according to protocols requiring standardized refrigerated centrifugation, aliquoting of samples into 2-D barcoded freezing vials and subsequent freezing at -80°C.
[0291] After delivery, preterm birth cases were reviewed individually to determine whether their status was sponta...
Embodiment 3
[0361] Example 3. Correlation of mass spectrometry and immunoassay data
[0362] This example shows the results of a Myriad RBM screen identifying IBP4 as well as other individual biomarkers of sPTB at early, mid and late gestational age acquisition windows, (2) correlation of MS and immunoassay results for SHBG / IBP4, and ( 3) Clinical data related to SHBG as a biomarker of sPTB.
[0363] RBM data
[0364] Briefly, RBM assayed 40 cases and 40 controls from PAPR (20 / 20 from early window, 10 / 10 from mid window, 10 / 10 from late window). RBM used Human Discovery MAP 250+v2.0 (Myriad RBM, Austin, TX). The goal of these analyzes was to develop a multivariate model using multiple analytes to predict PTB. We used four modeling methods: random forest (rf), boosting, lasso and logistic (logit) methods. We performed a first round of variable selection, where each method independently selected the best 15 variables for that method. From these 15 variables, the area under the ROC curv...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com